Skip to content

Drug interactions

Cabozantinib + Erythromycin

Severity: Moderate

Cabozantinib and Erythromycin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erythromycin is a moderate CYP3A4 inhibitor and may increase cabozantinib concentrations. Higher exposure may increase toxicities such as diarrhea, hypertension, hemorrhage and hand-foot syndrome.

What this interaction means in plain words

Cabozantinib and Erythromycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cabozantinib belongs to Oncology; Erythromycin belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated cabozantinib metabolism.

What to do

Monitor for cabozantinib adverse effects and reduce the dose if toxicity develops. Consider a non-CYP3A4-inhibiting antibiotic where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cabozantinib and Erythromycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cabozantinib with Erythromycin?

MediHelp rates the interaction as moderate. Cabozantinib and Erythromycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erythromycin is a moderate CYP3A4 inhibitor and may increase cabozantinib concentrations. Higher exposure may increase toxicities such as diarrhea, hypertension, hemorrhage and hand-foot syndrome.

How serious is the interaction between Cabozantinib and Erythromycin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for cabozantinib adverse effects and reduce the dose if toxicity develops. Consider a non-CYP3A4-inhibiting antibiotic where possible.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in